Capricor Therapeutics Inc (CAPR.OQ)
CAPR.OQ on NASDAQ Stock Exchange Capital Market
0.90USD
17 Oct 2018
0.90USD
17 Oct 2018
Change (% chg)
-- (--)
-- (--)
Prev Close
$0.90
$0.90
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
25,812
25,812
52-wk High
$3.19
$3.19
52-wk Low
$0.88
$0.88
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Jun '18 | 0.40 | -0.142 |
| Mar '18 | 0.40 | -0.136 | |
| FY 2017 | Dec '17 | 0.48 | 0.306 |
| Sep '17 | 0.31 | -0.117 | |
| Jun '17 | 1.00 | -0.157 | |
| Mar '17 | 0.88 | -0.171 | |
| FY 2016 | Dec '16 | 0.91 | -0.211 |
| Sep '16 | 0.75 | -0.292 | |
| Jun '16 | 1.13 | -0.261 | |
| Mar '16 | 1.22 | -0.258 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Dec-18 | 2 | 0.51 | 1.03 | 0.00 | -- |
| Year Ending Dec-18 | 2 | 1.75 | 2.70 | 0.80 | 4.10 |
| Year Ending Dec-19 | 2 | 1.40 | 2.80 | 0.00 | 4.10 |
| Earnings (per share) | |||||
| Quarter Ending Dec-18 | 2 | -0.14 | -0.11 | -0.18 | -- |
| Year Ending Dec-18 | 2 | -0.57 | -0.53 | -0.62 | -0.76 |
| Year Ending Dec-19 | 2 | -0.50 | -0.47 | -0.53 | -0.76 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 85.83 | 33.69 | |
| P/E High - Last 5 Yrs. | -- | 288.76 | 45.21 | |
| P/E Low - Last 5 Yrs. | -- | 90.17 | 23.79 | |
| Beta | -2.65 | 0.93 | 0.88 | |
| Price to Sales (TTM) | 19.03 | 123.60 | 5.82 | |
| Price to Book (MRQ) | -- | 15.31 | 4.89 | |
| Price to Tangible Book (MRQ) | -- | 14.52 | 6.52 | |
| Price to Cash Flow (TTM) | -- | 70.45 | 22.95 | |
| % Owned Institutions | 3.23 | 14.08 | 2.14 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.33 | 1.51 | |
| Dividend Yield - 5 Year Avg | -- | 0.24 | 1.52 | |
| Dividend 5 Year Growth Rate | -- | 2.55 | 5.39 | |
| Payout Ratio(TTM) | -- | 16.83 | 43.91 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | -11.80 | 413.48 | 8.02 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -26.18 | 103.91 | 5.75 | |
| Sales - 5 Yr. Growth Rate | 24.17 | 30.81 | 9.88 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 39.94 | 24.33 | 23.65 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 8.12 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 37.81 | 10.95 | |
| Capital Spending - 5 Yr. Growth Rate | 149.85 | 38.61 | 14.90 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 1.94 | 2.25 |
| Current Ratio (MRQ) | 0.82 | 5.34 | 3.05 |
| LT Debt to Equity (MRQ) | -- | 34.95 | 12.73 |
| Total Debt to Equity (MRQ) | -- | 36.76 | 17.15 |
| Interest Coverage (TTM) | -58.74 | -97.17 | 37.58 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 40.15 | 54.90 | |
| Gross Margin - 5 Yr. Avg. | -- | 49.21 | 52.43 | |
| EBITD Margin (TTM) | -423.45 | -- | -- | |
| EBITD - 5 Yr. Avg | -265.04 | -575.88 | 11.08 | |
| Operating Margin (TTM) | -470.06 | -770.08 | 4.31 | |
| Operating Margin - 5 Yr. Avg. | -287.51 | -596.20 | 6.43 | |
| Pre-Tax Margin (TTM) | -481.18 | -732.14 | 5.36 | |
| Pre-Tax Margin - 5 Yr. Avg. | -292.39 | -601.79 | 6.86 | |
| Net Profit Margin (TTM) | -481.18 | -733.08 | 1.64 | |
| Net Profit Margin - 5 Yr. Avg. | -292.39 | -604.76 | 3.11 | |
| Effective Tax Rate (TTM) | -- | 23.64 | 23.24 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 18.79 | 24.16 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | -- | 22,788,701 | 810,573,943 | |
| Net Income/Employee (TTM) | -- | 1,717,126 | 95,338,757 | |
| Receivable Turnover (TTM) | 13.29 | 19.81 | 5.77 | |
| Inventory Turnover (TTM) | -- | 2.38 | 3.62 | |
| Asset Turnover (TTM) | 0.25 | 0.40 | 0.92 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -120.88 | -1.09 | 10.92 | |
| Return on Assets - 5 Yr. Avg. | -96.30 | 3.20 | 12.03 | |
| Return on Investment (TTM) | -645.84 | 0.58 | 14.30 | |
| Return on Investment - 5 Yr. Avg. | -149.85 | 2.28 | 15.63 | |
| Return on Equity (TTM) | -- | 1.62 | 16.03 | |
| Return on Equity - 5 Yr. Avg. | -- | 3.07 | 16.90 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -27.53 | 99.55 | 24.17 |
| EPS (TTM) % | -25.39 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Capricor Therapeutics Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 177.67 | 168.10 | 99 | 59 |
| 13 Week | 326.87 | 306.08 | 99 | 63 |
| 26 Week | -0.69 | -8.24 | 99 | 76 |
| 52 Week | -15.13 | -28.07 | 77 | 47 |
| YTD | 7.52 | -5.58 | 99 | 57 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 7.89% |
| # of Holders: | 21 |
| Total Shares Held: | 2,426,666 |
| 3 Mo. Net Change: | 0 |
| # New Positions: | 0 |
| # Closed Positions: | 0 |
| # Increased Positions: | 0 |
| # Reduced Positions: | 0 |
| # Net Buyers: | 0 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.